μ-Opioid receptors, the product of the OPRM1 gene, have been demonstrated on several cancer cell lines including breast cancer, non-small cell lung cancer, adenocarcinoma and gastric carcinoma [19–21]. The gene discussed is OPRM1; the disease is adenocarcinoma.